Tourmaline Bio, Inc. Quarterly Debt-to-equity in % from Q3 2021 to Q2 2024

Taxonomy & unit: ratio: %
Description: Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary: Tourmaline Bio, Inc. quarterly Debt-to-equity history and growth rate from Q3 2021 to Q2 2024.
Tourmaline Bio, Inc. Debt-to-equity for the quarter ending June 30, 2024 was 2.4 %, a 92.7% decline year-over-year.

Debt-to-equity, Quarterly (%)

Debt-to-equity, YoY Quarterly Growth (%)

Period	Value	YoY Chg	Change %	Date
Q2 2024	2.4	-30.6	-92.7%	Jun 30, 2024
Q1 2024	4.42	-5.17	-53.9%	Mar 31, 2024
Q4 2023	12.6	+6.88	+121%	Dec 31, 2023
Q3 2023	58.5	+51.9	+786%	Sep 30, 2023
Q2 2023	33	+27.9	+541%	Jun 30, 2023
Q1 2023	9.59	+5.45	+132%	Mar 31, 2023
Q4 2022	5.68	+0.44	+8.4%	Dec 31, 2022
Q3 2022	6.6	+1.78	+36.9%	Sep 30, 2022
Q2 2022	5.15			Jun 30, 2022
Q1 2022	4.14			Mar 31, 2022
Q4 2021	5.24			Dec 31, 2021
Q3 2021	4.82			Sep 30, 2021

* An asterisk sign (*) next to the value indicates that the value is likely invalid.